Alkermes Plc (ALKS)
45.83
-0.14
(-0.30%)
USD |
NASDAQ |
Sep 14, 16:00
45.80
-0.03
(-0.07%)
After-Hours: 20:00
Alkermes Enterprise Value : 8.594B for Sept. 14, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 8.594B |
| September 11, 2026 | 8.618B |
| September 10, 2026 | 8.641B |
| September 09, 2026 | 8.522B |
| September 08, 2026 | 8.537B |
| September 04, 2026 | 8.640B |
| September 03, 2026 | 8.770B |
| September 02, 2026 | 8.911B |
| September 01, 2026 | 8.824B |
| August 31, 2026 | 8.789B |
| August 28, 2026 | 8.859B |
| August 27, 2026 | 9.109B |
| August 26, 2026 | 9.152B |
| August 25, 2026 | 9.161B |
| August 24, 2026 | 9.104B |
| August 21, 2026 | 9.013B |
| August 20, 2026 | 8.961B |
| August 19, 2026 | 9.323B |
| August 18, 2026 | 9.206B |
| August 17, 2026 | 9.268B |
| August 14, 2026 | 9.136B |
| August 13, 2026 | 9.201B |
| August 12, 2026 | 9.340B |
| August 11, 2026 | 9.161B |
| August 10, 2026 | 9.193B |
| Date | Value |
|---|---|
| August 07, 2026 | 9.154B |
| August 06, 2026 | 9.020B |
| August 05, 2026 | 9.228B |
| August 04, 2026 | 9.238B |
| August 03, 2026 | 9.214B |
| July 31, 2026 | 9.124B |
| July 30, 2026 | 9.298B |
| July 29, 2026 | 9.015B |
| July 28, 2026 | 9.377B |
| July 27, 2026 | 9.750B |
| July 24, 2026 | 9.777B |
| July 23, 2026 | 9.791B |
| July 22, 2026 | 9.725B |
| July 21, 2026 | 9.771B |
| July 20, 2026 | 9.581B |
| July 17, 2026 | 9.749B |
| July 16, 2026 | 9.618B |
| July 15, 2026 | 9.625B |
| July 14, 2026 | 9.561B |
| July 13, 2026 | 9.606B |
| July 10, 2026 | 9.618B |
| July 09, 2026 | 9.926B |
| July 08, 2026 | 10.01B |
| July 07, 2026 | 10.17B |
| July 06, 2026 | 10.15B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amarin Corp. Plc | -15.56M |
| Jazz Pharmaceuticals Plc | 18.14B |
| Prothena Corp. Plc | 177.25M |
| Biogen, Inc. | 39.17B |
| Cytokinetics, Inc. | 10.16B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.501M |
| Revenue (Quarterly) | 496.01M |
| Total Expenses (Quarterly) | 495.51M |
| EPS Diluted (Quarterly) | 0.0029 |
| Gross Profit Margin (Quarterly) | 75.30% |
| Profit Margin (Quarterly) | 0.10% |
| Earnings Yield | 0.84% |
| Operating Earnings Yield | 1.85% |
| Normalized Earnings Yield | 1.073 |